Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	49.81	163.64	55.9	140.52	232.69	297.1
Short-Term Investments	268.35	208.7	317.27	215.88	156.05	185.62
Cash & Short-Term Investments	318.16	372.34	373.18	356.39	388.74	482.72
Cash Growth	-3.68%	-0.22%	4.71%	-8.32%	-19.47%	58.73%
Prepaid Expenses	6.33	5.85	5.05	7.67	3.32	4.63
Total Current Assets	324.49	378.18	378.22	364.06	392.06	487.35
Property, Plant & Equipment	80.39	83.32	87.59	77.65	72.35	70.64
Long-Term Investments	-	-	34.32	43.28	-	-
Goodwill	39.15	39.15	39.15	39.15	30.82	30.82
Other Intangible Assets	25.15	25.15	25.15	25.72	-	-
Other Long-Term Assets	1.88	1.89	1.91	1.95	1.8	2.02
Total Assets	471.07	527.7	566.34	551.81	497.02	590.82
Accounts Payable	2.95	1.63	1.77	2.27	0.48	0.84
Accrued Expenses	29.44	36.02	29.8	30.54	17.81	22.29
Current Portion of Long-Term Debt	-	-	-	-	-	4.88
Current Portion of Leases	2.88	2.86	2.72	2.51	2.55	2.27
Current Unearned Revenue	-	-	-	0.6	0.6	0.59
Other Current Liabilities	0.05	0.19	14.21	3.25	0.73	1.76
Total Current Liabilities	35.31	40.68	48.51	39.17	22.17	32.62
Long-Term Debt	-	-	-	-	-	35.07
Long-Term Leases	22.48	22.64	22.33	20.36	20.05	19.49
Other Long-Term Liabilities	1.14	1.14	2.94	2.6	0.08	0.14
Total Liabilities	58.93	64.47	73.77	62.12	42.3	87.31
Common Stock	1.07	1.07	0.9	0.79	0.65	0.61
Additional Paid-In Capital	1,691	1,680	1,451	1,203	946.15	825.79
Retained Earnings	-1,279	-1,218	-959.37	-713.78	-491.91	-322.84
Treasury Stock	-	-	-	-0.05	-	-
Comprehensive Income & Other	-0.03	0.07	0.32	-0.36	-0.16	-0.04
Total Common Equity	412.14	463.23	492.57	489.69	454.72	503.52
Shareholders' Equity	412.14	463.23	492.57	489.69	454.72	503.52
Total Liabilities & Equity	471.07	527.7	566.34	551.81	497.02	590.82
Total Debt	25.35	25.5	25.04	22.87	22.6	61.7
Net Cash (Debt)	292.81	346.84	348.13	333.53	366.14	421.02
Net Cash Growth	-3.79%	-0.37%	4.38%	-8.91%	-13.04%	64.03%
Net Cash Per Share	2.96	3.66	4.14	4.89	5.79	7.60
Filing Date Shares Outstanding	107.74	106.63	90.5	79.35	64.51	61.78
Total Common Shares Outstanding	106.75	106.45	90.28	79.12	64.51	61
Working Capital	289.18	337.5	329.72	324.89	369.89	454.73
Book Value Per Share	3.86	4.35	5.46	6.19	7.05	8.25
Tangible Book Value	347.83	398.93	428.27	424.81	423.91	472.7
Tangible Book Value Per Share	3.26	3.75	4.74	5.37	6.57	7.75
Machinery	49.04	48.85	44.58	35.61	25.21	19.84
Leasehold Improvements	7.33	7.28	6.72	0.59	0.41	0.03

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q